Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Shares, Euro 0.09 nominal value per share
-
Shares outstanding
-
75,893,250
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
18,590,455
-
Shares change
-
+585,382
-
Total reported value, excl. options
-
$299,121,000
-
Value change
-
+$19,430,635
-
Number of buys
-
26
-
Number of sells
-
13
-
Price
-
$16.09
Institutional Holders of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) as of Q2 2020
As of 30 Jun 2020 Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) had 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,590,455 shares of stock of the company.
Largest 10 holders included BVF INC/IL, FEDERATED HERMES, INC., BAKER BROS. ADVISORS LP, Medicxi Ventures Management (Jersey) Ltd, Sofinnova Investments, Inc., DRIEHAUS CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, MPM Oncology Impact Management LP, Cormorant Asset Management, LP, and HILLHOUSE CAPITAL ADVISORS, LTD..
This table shows 42 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.